|
1）Global initiative for chronic obstructive lung disease. Global strategy for diagnosis, management. and prevention of chronic obstructive lung disease. updated February 2013 (Accessed at http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html)
|
|
|
|
|
2）Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124: 783-801
|
|
|
|
|
3）Opitz B, van Laak V, Eitel J, et al. Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med. 2010; 181: 1294-309
|
|
|
|
|
|
4）Mallia P, Johnston SL. How viral infections cause exacerbation of airway diseases. Chest. 2006; 130: 1203-10
|
|
|
|
|
|
5）Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev. 2004; 56: 515-48
|
|
|
|
|
|
6）Rahman I. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys. 2005; 43: 167-88
|
|
|
|
|
|
7）Ichinose M, Sugiura H, Yamagata S, et al. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med. 2000; 162: 701-6
|
|
|
|
|
|
8）Sethi S, Maloney J, Grove L, et al. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 173: 991-8
|
|
|
|
|
|
9）Gaschler GJ, Zavitz CC, Bauer CM, et al. Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages. Am J Respir Cell Mol Biol. 2008; 38: 218-26
|
|
|
|
|
|
10）Chen H, Cowan MJ, Hasday JD, et al. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol. 2007; 179: 6097-106
|
|
|
|
|
|
11）Droemann D, Goldmann T, Tiedje T, et al. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res. 2005; 6: 68
|
|
|
|
|
|
12）Wang R, Ahmed J, Wang G, et al. Airway epithelial expression of TLR5 is downregulated in healthy smokers and smokers with chronic obstructive pulmonary disease. J Immunol. 2012; 189: 2217-25
|
|
|
|
|
|
13）Rohde G, Klein W, Arinir U, et al. Association of the ASP299GLY TLR4 polymorphism with COPD. Respir Med. 2006; 100: 892-6
|
|
|
|
|
|
14）Budulac SE, Boezen HM, Hiemstra PS, et al. Toll-like receptor （TLR2 and TLR4） polymorphisms and chronic obstructive pulmonary disease. PLoS One. 2012; 7: e43124
|
|
|
|
|
|
15）Ito M, Hanaoka M, Droma Y, et al. The association of Toll-like receptor 4 gene polymorphisms with the development of emphysema in Japanese subjects: a case control study. BMC Res Notes. 2012; 5: 36
|
|
|
|
|
|
16）Zhang X, Shan P, Jiang G, et al. Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest. 2006; 116: 3050-9
|
|
|
|
|
|
17）An CH, Wang XM, Lam HC, et al. TLR4 deficiency promotes autophagy during cigarette smoke-induced pulmonary emphysema. Am J Physiol Lung Cell Mol Physiol. 2012; 303: L748-57
|
|
|
|
|
|
18）Lee SW, Kim DR, Kim TJ, et al. The association of down-regulated toll-like receptor 4 expression with airflow limitation and emphysema in smokers. Respir Res. 2012; 13: 106
|
|
|
|
|
|
19）Karimi K, Sarir H, Mortaz E, et al. Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res. 2006; 7: 66
|
|
|
|
|
|
20）Yanagisawa S, Koarai A, Sugiura H, et al. Oxidative stress augments toll-like receptor 8 mediated neutrophilic responses in healthy subjects. Respir Res. 2009; 10: 50
|
|
|
|
|
|
21）Mortaz E, Adcock IM, Ito K, et al. Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor. Eur Respir J. 2010; 36: 1143-54
|
|
|
|
|
|
22）Koarai A, Sugiura H, Yanagisawa S, et al. Oxidative stress enhances toll-like receptor 3 response to double-stranded RNA in airway epithelial cells. Am J Respir Cell Mol Biol. 2010; 42: 651-60
|
|
|
|
|
|
23）Sukkar MB, Xie S, Khorasani NM, et al. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol. 2006; 118: 641-8
|
|
|
|
|
|
24）Pons J, Sauleda J, Regueiro V, et al. Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease. Respir Res. 2006; 7: 64
|
|
|
|
|
|
25）Pace E, Giarratano A, Ferraro M, et al. TLR4 upregulation underpins airway neutrophilia in smokers with chronic obstructive pulmonary disease and acute respiratory failure. Hum Immunol. 2011; 72: 54-62
|
|
|
|
|
|
26）Koarai A, Yanagisawa S, Sugiura H, et al. Cigarette smoke augments the expression and responses of toll-like receptor 3 in human macrophages. Respirology. 2012; 17: 1018-25
|
|
|
|
|
|
27）Nadigel J, Prefontaine D, Baglole CJ, et al. Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8 (+) T cells in chronic obstructive pulmonary disease. Respir Res. 2011; 12: 149
|
|
|
|
|
|
28）Baines KJ, Simpson JL, Gibson PG. Innate immune responses are increased in chronic obstructive pulmonary disease. PLoS One. 2011; 6: e18426
|
|
|
|
|
|
29）Geraghty P, Dabo AJ, D’Armiento J. TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J Biol Chem. 2011; 286: 30211-8
|
|
|
|
|
|
30）Pace E, Ferraro M, Minervini MI, et al. Beta defensin-2 is reduced in central but not in distal airways of smoker COPD patients. PLoS One. 2012: 7: e33601
|
|
|
|
|
|
31）Freeman CM, Martinez FJ, Han MK, et al. Lung CD8＋ T cells in COPD have increased expression of bacterial TLRs. Respir Res. 2013; 14: 13
|
|
|
|
|
|
32）Doz E, Noulin N, Boichot E, et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol. 2008; 180: 1169-78
|
|
|
|
|
|
33）Bauer RN, Diaz-Sanchez D, Jaspers I. Effects of air pollutants on innate immunity: The role of Toll-like receptors and nucleotide-binding oligomerization domain–like receptors. J Allergy Clin Immunol. 2012; 129: 14-24
|
|
|
|
|
|
34）Bezemer GF, Sagar S, van Bergenhenegouwen J, et al. Dual role of toll-like receptors in asthma and chronic obstructive pulmonary disease. Pharmacol Rev. 2012; 64: 337-58
|
|
|
|
|
|
35）Penzo M, Molteni R, Suda T, et al. Inhibitor of NF-kappaB kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis. J Immunol. 2010; 184: 4497-509
|
|
|
|
|
|
36）Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004; 279: 7370-7
|
|
|
|
|
|
37）Yang H, Tracey KJ. Targeting HMGB1 in inflammation. Biochim Biophys Acta. 2010; 1799: 149-56
|
|
|
|
|
|
38）Ferhani N, Letuve S, Kozhich A, et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 181: 917-27
|
|
|
|
|
|
39）Hou C, Zhao H, Liu L, et al. High mobility group protein B1 （HMGB1） in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med. 2011; 17: 807-15
|
|
|
|
|
|
40）Kanazawa H, Tochino Y, Asai K, et al. Validity of HMGB1 measurement in epithelial lining fluid in patients with COPD. Eur J Clin Invest. 2012; 42: 419-26
|
|
|
|
|
|
41）Seemungal T, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 164: 1618-23
|
|
|
|
|
|
42）Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002; 57: 847-52
|
|
|
|
|
|
43）Hudy MH, Traves SL, Wiehler S, et al. Cigarette smoke modulates rhinovirus-induced airway epithelial cell chemokine production. Eur Respir J. 2010; 35: 1256-63
|
|
|
|
|
|
44）Schneider D, Ganesan S, Comstock AT, et al. Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 182: 332-40
|
|
|
|
|
|
45）Kang MJ, Lee CG, Lee JY, et al. Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest. 2008; 118: 2771-84
|
|
|
|
|
|
46）Calven J, Yudina Y, Hallgren O, et al. Viral stimuli trigger exaggerated thymic stromal lymphopoietin expression by chronic obstructive pulmonary disease epithelium: role of endosomal TLR3 and cytosolic RIG-I-like helicases. J Innate Immun. 2012; 4: 86-99
|
|
|
|
|
|
47）Todt JC, Freeman CM, Brown JP, et al. Smoking decreases the response of human lung macrophages to double-stranded RNA by reducing TLR3 expression. Respir Res. 2013; 14: 33
|
|
|
|
|
|
48）Sugiura H, Ichikawa T, Koarai A, et al. Activation of Toll-like receptor 3 augments myofibroblast differentiation. Am J Respir Cell Mol Biol. 2009; 40: 654-62
|
|
|
|
|